Inflammatory bowel diseases -Crohn's disease and ulcerative colitisare an extremely urgent problem both in Russia and around the world. A serious obstacle is the objective difficulties in the treatment of such patients due to the characteristics of the diseases themselves, due to the complexity of pathogenesis. To date, the most successful methods of pathogenetic therapy are anticytokines and the use of drugs aimed at suppressing the T-cell response. At the same time, although the arsenal of pathogenetic drugs for patients with inflammatory bowel diseases has been significantly expanded in recent years, there is an objective need to develop new therapy options, which is associated with insufficiently satisfactory treatment results for these patients. This publication is a literature review on the main targeted areas of therapy for these diseases in modern conditions -the advantages and disadvantages of individual pathogenetic approaches in the treatment of ulcerative colitis and Crohn's disease. The article discusses such approaches as anticytokine therapy, blockade of the a4b7 subunit of lymphocytes, the effect on the endothelial adhesion molecule MAdCAM-1, the use of Janus kinase inhibitors, blockade of sphingosine-1-phosphate receptors. The advantages and disadvantages of these methods are given.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.